Gofen & Glossberg LLC Atreca, Inc. Transaction History

Gofen & Glossberg LLC

  • $3.89 Billion
  • Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Atreca, Inc. stock. As of the latest transaction made, Gofen & Glossberg LLC holds 20,000 shares of BCEL stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 25,000 20.0%
Holding current value
$0
Previous $39,000 58.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023
SELL
$0.78 - $1.68 $3,900 - $8,400
-5,000 Reduced 20.0%
20,000 $16,000
Q2 2022

Jul 14, 2022
BUY
$1.56 - $3.25 $15,600 - $32,500
10,000 Added 66.67%
25,000 $45,000
Q1 2022

Apr 14, 2022
BUY
$1.61 - $5.2 $24,150 - $78,000
15,000 New
15,000 $48,000

Others Institutions Holding BCEL

# of Institutions
2
Shares Held
30.6K
Call Options Held
0
Put Options Held
0
View Full List

About Atreca, Inc.

BCEL Quotes by TradingView
  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email